Stryker to acquire MAKO Surgical at $30/share cash (~$1.65B); platform diagnostics-enabled medtech (robotics) included for orthopedics franchise expansion.
Did it work? Outcome assessment
Strategic verdict
Achieved Stated Rationale
Financial impact
Accretive
Pipeline outcome
Assets Advanced
Assessment window: 5yr post-close.
Key facts
AnnouncedSep 25, 2013
ClosedDec 19, 2013
Deal value$1.6B
Deal typeAcquisition/Merger
Therapeutic areaOrthopedic robotic surgery (knee/hip)
IndicationsOrthopedic robotic surgery (knee/hip)
Key assetsRIO Robotic Arm Interactive Orthopedic System; RESTORIS implants
MechanismRobotic-arm-assisted orthopedic surgery platform